Federated Hermes’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$96K Sell
343
-454
-57% -$119K ﹤0.01% 1619
2026
Q1
$213K Buy
797
+280
+54% +$75.8K ﹤0.01% 1478
2025
Q4
$130K Buy
517
+156
+43% +$41.4K ﹤0.01% 1552
2025
Q3
$104K Sell
361
-3
-0.8% -$804 ﹤0.01% 1579
2025
Q2
$95.6K Sell
364
-462
-56% -$112K ﹤0.01% 1589
2025
Q1
$192K Buy
826
+538
+187% +$131K ﹤0.01% 1489
2024
Q4
$66K Sell
288
-13
-4% -$2.98K ﹤0.01% 1616
2024
Q3
$67.3K Buy
301
+8
+3% +$1.76K ﹤0.01% 1609
2024
Q2
$59.6K Sell
293
-20
-6% -$4.07K ﹤0.01% 1603
2024
Q1
$68.4K Sell
313
-23
-7% -$5.07K ﹤0.01% 1599
2023
Q4
$76.4K Sell
336
-19
-5% -$3.99K ﹤0.01% 1605
2023
Q3
$71.4K Sell
355
-432
-55% -$91.1K ﹤0.01% 1638
2023
Q2
$163K Buy
787
+82
+12% +$15.9K ﹤0.01% 1576
2023
Q1
$139K Sell
705
-515
-42% -$106K ﹤0.01% 1633
2022
Q4
$247K Sell
1,220
-791
-39% -$155K ﹤0.01% 1524
2022
Q3
$354K Sell
2,011
-103
-5% -$21.1K ﹤0.01% 1416
2022
Q2
$426K Sell
2,114
-2,287
-52% -$488K ﹤0.01% 1396
2022
Q1
$997K Sell
4,401
-20
-0.5% -$4.7K ﹤0.01% 1251
2021
Q4
$1.19M Buy
4,421
+1,233
+39% +$305K ﹤0.01% 1215
2021
Q3
$771K Buy
3,188
+157
+5% +$39.6K ﹤0.01% 1375
2021
Q2
$718K Buy
3,031
+2,168
+251% +$494K ﹤0.01% 1412
2021
Q1
$189K Sell
863
-29
-3% -$5.82K ﹤0.01% 1701
2020
Q4
$156K Sell
892
-249
-22% -$43K ﹤0.01% 1702
2020
Q3
$184K Sell
1,141
-174
-13% -$27.6K ﹤0.01% 1666
2020
Q2
$188K Buy
1,315
+355
+37% +$49.1K ﹤0.01% 1633
2020
Q1
$104K Sell
960
-97
-9% -$14K ﹤0.01% 1643
2019
Q4
$154K Sell
1,057
-553
-34% -$79.8K ﹤0.01% 1635
2019
Q3
$232K Buy
1,610
+11
+0.7% +$1.6K ﹤0.01% 1560
2019
Q2
$238K Buy
1,599
+1,257
+368% +$175K ﹤0.01% 1536
2019
Q1
$45K Sell
342
-2,480
-88% -$306K ﹤0.01% 1662
2018
Q4
$306K Buy
2,822
+1,190
+73% +$159K ﹤0.01% 1504
2018
Q3
$243K Sell
1,632
-38
-2% -$5.78K ﹤0.01% 1584
2018
Q2
$258K Sell
1,670
-262
-14% -$39.5K ﹤0.01% 1506
2018
Q1
$269K Sell
1,932
-5,096
-73% -$749K ﹤0.01% 1477
2017
Q4
$963K Buy
7,028
+2,406
+52% +$318K ﹤0.01% 1230
2017
Q3
$599K Sell
4,622
-3,127
-40% -$417K ﹤0.01% 1322
2017
Q2
$1.03M Sell
7,749
-244,491
-97% -$29.9M ﹤0.01% 1187
2017
Q1
$31.1M Buy
252,240
+12,839
+5% +$1.52M 0.09% 201
2016
Q4
$26.4M Buy
239,401
+123,634
+107% +$13.7M 0.08% 216
2016
Q3
$13.7M Buy
115,767
+112,886
+3,918% +$13.3M 0.04% 354
2016
Q2
$322K Sell
2,881
-2,547
-47% -$274K ﹤0.01% 1386
2016
Q1
$546K Sell
5,428
-181
-3% -$17.4K ﹤0.01% 1259
2015
Q4
$596K Buy
5,609
+2,593
+86% +$268K ﹤0.01% 1245
2015
Q3
$281K Sell
3,016
-35
-1% -$3.62K ﹤0.01% 1435
2015
Q2
$318K Sell
3,051
-115,277
-97% -$12M ﹤0.01% 1423
2015
Q1
$12.8M Buy
118,328
+11,512
+11% +$1.18M 0.04% 401
2014
Q4
$9.9M Buy
106,816
+2,792
+3% +$247K 0.03% 457
2014
Q3
$9.09M Buy
104,024
+11,626
+13% +$1.05M 0.03% 472
2014
Q2
$8.13M Sell
92,398
-4,075
-4% -$353K 0.03% 507
2014
Q1
$8.14M Buy
96,473
+33,497
+53% +$2.67M 0.03% 520
2013
Q4
$4.94M Buy
62,976
+18,065
+40% +$1.54M 0.02% 632
2013
Q3
$3.83M Sell
44,911
-1,380
-3% -$116K 0.01% 677
2013
Q2
$3.98M Buy
+46,291
New +$3.84M 0.02% 647

Other funds holding LH

Federated Hermes's LH Position: Q2 2026 in Review

Federated Hermes reduced its Labcorp (LH) stake by 57% in Q2 2026, selling an estimated $119K and leaving 343 shares worth $96K. The position accounts for ﹤0.01% of the portfolio, ranked #1619.

Federated Hermes first reported a position in LH in Q2 2013 and has held it in 53 quarters since. The position peaked at $31.1M in Q1 2017. 1,051 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Federated Hermes held 343 shares of Labcorp worth $96K as of Q2 2026.
  • Federated Hermes sold 454 Labcorp shares in Q2 2026, an estimated $119K.
  • Labcorp made up ﹤0.01% of Federated Hermes's portfolio in Q2 2026, its #1619 holding.
  • Federated Hermes first reported a position in Labcorp in Q2 2013 and has held it in 53 quarters since.
  • Federated Hermes's Labcorp position peaked at $31.1M in Q1 2017.
  • 1,051 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.